Cargando…

Diabetic Retinopathy: Targeting Vasoregression

Detalles Bibliográficos
Autores principales:	Hammes, Hans-Peter, Feng, Yuxi, Pfister, Frederick, Brownlee, Michael
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012202/ https://www.ncbi.nlm.nih.gov/pubmed/21193734 http://dx.doi.org/10.2337/db10-0454

Ejemplares similares

Vasoregression Linked to Neuronal Damage in the Rat with Defect of Polycystin-2
por: Feng, Yuxi, et al.
Publicado: (2009)

Gene Expression Profiling of Vasoregression in the Retina—Involvement of Microglial Cells
por: Feng, Yuxi, et al.
Publicado: (2011)

Microglial Activation Is Associated With Vasoprotection in a Rat Model of Inflammatory Retinal Vasoregression
por: Riemann, Sarah, et al.
Publicado: (2021)

MicroRNA-124 Alleviates Retinal Vasoregression via Regulating Microglial Polarization
por: Chen, Ying, et al.
Publicado: (2021)

Mitochondrial Stability in Diabetic Retinopathy: Lessons Learned From Epigenetics
por: Kowluru, Renu A.
Publicado: (2019)

Pericyte Migration: A Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy
por: Pfister, Frederick, et al.
Publicado: (2008)

Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access
por: Lee, David J, et al.
Publicado: (2014)

Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
por: Titchenell, Paul M., et al.
Publicado: (2013)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
por: Hardie, D. Grahame
Publicado: (2013)

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
por: Andersen, Dana K., et al.
Publicado: (2017)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

The American Diabetes Association Diabetes Research Perspective
por: Fonseca, Vivian A., et al.
Publicado: (2012)

American Diabetes Association Research Symposium: Diabetes and the Brain
por: Seaquist, Elizabeth R., et al.
Publicado: (2012)

Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets
por: Coucha, Maha, et al.
Publicado: (2015)

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
por: Semenkovich, Clay F., et al.
Publicado: (2015)

COVID-19–Induced New-Onset Diabetes: Trends and Technologies
por: Metwally, Ahmed A., et al.
Publicado: (2021)

The Barrier of Hypoglycemia in Diabetes
por: Cryer, Philip E.
Publicado: (2008)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Diabetes Research: A Perspective From the National Institute of Diabetes and Digestive and Kidney Diseases
por: Fradkin, Judith E., et al.
Publicado: (2013)

Epidemiological Issues in Diabetic Retinopathy
por: Scanlon, Peter H, et al.
Publicado: (2013)

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
por: Davidson, Jaime A, et al.
Publicado: (2014)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions
por: Nathan, David M., et al.
Publicado: (2013)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Diabetes Complications: The MicroRNA Perspective
por: Kantharidis, Phillip, et al.
Publicado: (2011)

Nutrient Sensing, Autophagy, and Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2012)

Clinical profile of diabetes mellitus in tuberculosis
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2015)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Economic aspects in the management of diabetes in Italy
por: Marcellusi, A, et al.
Publicado: (2016)

Celebrating 30 Years of Research Accomplishments of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Fradkin, Judith E., et al.
Publicado: (2013)

How Does Type 1 Diabetes Develop?: The Notion of Homicide or β-Cell Suicide Revisited
por: Atkinson, Mark A., et al.
Publicado: (2011)

Maternal Environment and the Transgenerational Cycle of Obesity and Diabetes
por: Dabelea, Dana, et al.
Publicado: (2011)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
por: Johnson, Richard J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l2e907raslnaoqcl14t9q19rgi